Health and Healthcare
732 Articles
A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand…
A Gilead Sciences bond offering and a key insider stock sale netting over $14 million should be considered by investors.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.
A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to…
Gilead Sciences reported disappointing third-quarter results after the market close on Monday.
Gilead Sciences is set to report its third-quarter earnings after the U.S. markets close on Tuesday.
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech…
In a new research report, Deutsche Bank analysts suggest investors focus on sectors like technology, health care, financials and selected…
A new research report from Merrill Lynch highlights 10 top catalyst-driven ideas for the fourth quarter.
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most…
A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…
A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy…
Jon OggStocks were firm yet again on Friday morning ahead of the PPI wholesale inflation report. Investors have been trying…
Our top personal finance-related articles today. Your wallet will thank you later.